I. Short Course on the Genetics of Addiction
August 18 – 23, 2012
II. August 20 Receipt Date for Cutting-Edge Basic Research Awards (CEBRA) (R21) http://grants.nih.gov/grants/guide/pa-files/PAR-12-086.html
III. NIDA Mini-Convention at the Society for Neuroscience https://seiservices.com/nida/frontiers2012/
IV. Constructing whole brain connectivity networks
V. NIH Director's Early Independence Awards (DP5) RFA-RM-12-018
I. Short Course on the Genetics of Addiction
August 18 – 23, 2012, Bar Harbor, Maine
This course emphasizes genetic applications and approaches to drug addiction research through methodological instruction based on literature, data sets and informatics resources drawn from studies of addiction related phenotypes. The course includes plenary sessions on major progress in addiction genetics, and discussion sessions in which students present their work for discussion on applications of genetic methods. Students will leave the course able to design and interpret genetic and genomic studies of addiction as they relate to their specific research question, and will be able to make use of current bioinformatics resources to identify research resources and make use of public data sources in their own research.
Registration:
• Registration fee is $1,500, and includes course materials, lodging and meals.
• Placement is limited to 35 attendees so prompt application is advised.
• Limited scholarships are be available to help attendees with travel expenses.
To apply for this event or for more information, including schedule, organizers and speaker list, please visit: http://courses.jax.org/2012/addiction.html
Or, contact Nancy Place at nancy.place@jax.org or by telephone at 207-288-6257.
Applications by women, minorities, and persons with disabilities are strongly encouraged.
Funding for this conference was made possible (in part) by R13 DA 032192-02 from the National Institute on Drug Abuse and The Howard Hughes Medical Institute.
II. August 20 Receipt Date for Cutting-Edge Basic Research Awards (CEBRA) (R21)
The NIDA Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to drug abuse and addiction and how to prevent and treat them. It supports research that is high-risk and potentially high-impact that is underrepresented or not included in NIDA's current portfolio. The proposed research should: (1) test a highly novel and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would have a substantial impact on current thinking; and/or (2) develop or adapt innovative techniques or methods for addiction research, or that have promising future applicability to drug abuse research. It is strongly recommended that you contact the CEBRA coordinator, Susan Volman (svolman@nida.nih.gov Ph. 301-435-1315), to discuss a potential CEBRA application before submitting to this FOA.
III. NIDA Mini-Convention at the Society for Neuroscience
National Institute on Drug Abuse Frontiers in Addiction Research Mini-Convention
Friday October 12, 2012
Sheraton New Orleans Hotel, 500 Canal Street, New Orleans, LA
Seating is limited. Please register online: https://seiservices.com/nida/frontiers2012/
The National Institute on Drug Abuse (NIDA) Mini-Convention, Frontiers in Addiction Research, will feature cutting-edge presentations and discussion of future directions in the neurobiology of drug abuse and addiction. The NIDA Mini-Convention includes four symposia, the SfN Jacob Waletzky Memorial Lecture and a poster session for early career investigators. The agenda this year includes:
8:00 – 8:15 Welcome: NIDA Director
8:15 – 9:35 Ghrelin, Leptin and Insulin Modulates Reward
9:35-10:10 Jacob P. Waletzky Memorial Lecture
10:30-12:15 Role of Phagocytes in Synaptic Plasticity & Remodeling in the Nervous System
12:15- 2:15 Early Career Investigators Poster Session
2:15-3:35 Brain Energetics and Neurotransmission: Fueling Neurons and Glia
3:50-5:25 Central Nervous System Immune Signaling and Addiction
IV. Constructing whole brain connectivity networks
Lead by Dr. Hong-Wei Dong at the Laboratory of Neuro Imaging, the UCLA Mouse Connectome Project (MCP) will construct the first three-dimensional digital atlas characterizing the neural networks of the entire mammalian brain. To accomplish this, the team uses a double coinjection circuit tracing method which simultaneously labels four different neuronal pathways, each tagged with a different fluorescent color. This injection strategy is unique in that it simultaneously reveals connections to and from brain regions, but more importantly, reveals how two different brain regions interact with one another. This latter feature is critical since it is the cooperative interactions between neural structures, or brain networks, that culminate in behavior. Injections are made systematically into anatomically defined structures starting from the olfactory bulb all the way to the brainstem.
To facilitate their use, the data are made available both to the neuroscience community and to the general public through an online, interactive visualization tool, the iConnectome (www.MouseConnectome.org). Viewers can navigate through the high-resolution, multi-colored brain pathways, which can be explored within a bright-field Nissl background and within their anatomic map based on a standard atlas (Allen Reference Atlas, Dong, 2007, Wiley). These two features help viewers more easily understand and analyze the data.
Currently, the iConnectome features 65 cases that showcase 130 injections and roughly 245 labeled pathways involving the olfactory bulb, cerebral cortex, and hypothalamus. Data involving more structures and pathways are being released on a monthly basis and the detailed analyses of these connectivity data also is underway. This project is supported by NIMH R01 MH094360-01A1) and a P41 Supplement (3P41RR013642-12S3).
V. NIH Director's Early Independence Awards (DP5) RFA-RM-12-018
The NIH Director's Early Independence Award Program supports exceptional investigators who wish to pursue independent research directly after completion of their terminal doctoral/research degree or clinical residency, thereby forgoing the traditional post-doctoral training period. Application deadline January 30, 2013 by 5PM local time.
------
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov<mailto:listserv@list.nih.gov>, Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email
- You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309
No comments:
Post a Comment